Published in Z Immunitatsforsch Immunobiol on April 01, 1977
Immune hemolysis: a simplified method for the preparation of EAC'4 with guinea pig or with human complement. J Immunol (1967) 8.06
Complement fixation on cell surfaces by 19S and 7S antibodies. Science (1965) 4.04
Hemolysin titration based on fixation of the activated first component of complement: evidence that one molecule of hemolysin suffices to sensitize an erythrocyte. J Immunol (1965) 3.42
Complement and Hemolysis. Science (1963) 2.73
Deficiency of the sixth component of complement in rabbits with an inherited complement defect. J Exp Med (1966) 2.73
BCG and cancer (first of two parts). N Engl J Med (1974) 2.13
Forssman antigen and antibody: preparation of water soluble antigen and measurement of antibody concentration by precipitin analysis, by C'1a fixation and by hemolytic activity. J Immunol (1966) 1.95
C'-1 fixation by human isoagglutinins: fixation of C'-1 by gamma-G and gamma-M but not by gamma-A antibody. J Immunol (1966) 1.80
Complement analysis in children with idiopathic membranoproliferative glomerulonephritis: a long-term follow-up. Pediatr Allergy Immunol (2001) 1.80
BCG and cancer. N Engl J Med (1974) 1.66
Neutralization of sensitized virus by purified components of complement. Proc Natl Acad Sci U S A (1970) 1.63
Immune hemolysis and the functional properties of the second (C2) and fourth (C4) components of complement. 3. The hemolytic efficiency of human and guinea pig C2 and C4. J Immunol (1971) 1.60
Tumor-specific antigen solubilized by hypertonic potassium chloride. J Natl Cancer Inst (1971) 1.46
Synthesis of the first component of human complement in vitro. J Exp Med (1968) 1.44
Production of the second (C2) and fourth (C4) components of guinea pig complement by single peritoneal cells: evidence that one cell may produce both components. J Immunol (1972) 1.44
In vitro synthesis of the first component of complement by guinea pig small intestine. Proc Natl Acad Sci U S A (1966) 1.30
Antigenicity of a new diethylnitrosamine-induced transplantable guinea pig hepatoma: pathology and formation of ascites variant. J Natl Cancer Inst (1968) 1.28
Tumor-graft rejection in syngeneic guinea pigs: evidence for a two-step mechanism. J Natl Cancer Inst (1970) 1.27
Mouse complement: the effect of sex hormones and castration on two of the late-acting components. J Exp Med (1967) 1.26
Purification of the first component of complement by zonal ultracentrifugation. J Immunol (1969) 1.26
The C'la fixation and transfer test: examples of its applicability to the detection and enumeration of antigens and antibodies at cell surfaces. J Immunol (1968) 1.25
Formation of C'-6 by rabbit liver tissue in vitro. Immunology (1968) 1.24
Neutralization of sensitized virus by the fourth component of complement. Science (1969) 1.21
Synthesis of the first component of guinea pig complement by columnar epithelial cells of the small intestine. J Immunol (1968) 1.19
Synthesis of the second component of guinea pig complement in vitro. J Immunol (1971) 1.16
Studies on complement defective rabbits. IV. Blood clearance of intravenously injected S. typhi by the reticuloendothelial system. Proc Soc Exp Biol Med (1965) 1.14
Immunotherapy of an intramuscular tumor in strain-2 guinea pigs: prevention of tumor growth by intradermal immunization and by systemic transfer of tumor immunity. J Natl Cancer Inst (1970) 1.14
Tumor-specific antigens detected by inhibition of macrophage migration. Science (1969) 1.13
125I protein A: applications to the quantitative determination of fluid phase and cell-bound IgG. J Immunol Methods (1977) 1.10
Immunochemical analyses of membrane-bound complement. Detection of the terminal complement complex and its similarity to "intrinsic" erythrocyte membrane proteins. Biochim Biophys Acta (1975) 1.10
Studies on the terminal stages of immune hemolysis. VI. Osmotic blockers of differing Stokes' radii detect complement-induced transmembrane channels of differing size. J Immunol (1979) 1.09
Immunoblot analysis of Schistosoma mansoni antigens with sera of schistosomiasis patients: diagnostic potential of an adult schistosome polypeptide. Clin Exp Immunol (1985) 1.07
Detection of bound C3 by a new immunochemical methods. J Immunol (1971) 1.06
Titration of the first component of complement on a molecular basis: suitability of IgM and unsuitability of IgG hemolysins as sensitizer. Immunochemistry (1969) 1.06
Genetic polymorphism of C3 and Bf in IgA nephropathy. Nephrol Dial Transplant (1987) 1.05
Heterogeneity of rabbit IgM antibody as detected by C'1a fixation. J Exp Med (1968) 1.04
Bithermic complement activation in cryoglobulinaemic serum. Eur J Clin Invest (1972) 1.02
Studies on the terminal stages of immune hemolysis. III. Distinction between the insertion of C9 and the formation of a transmembrane channel. J Immunol (1978) 1.02
Brief communication: antigenic relationship between Mycobacterium bovis (BCG) and a guinea pig hepatoma. J Natl Cancer Inst (1973) 1.00
Immunotherapy of cancer: an experimental model in syngeneic guinea pigs. Science (1970) 0.98
Efficiency of the first component of complement (C'1) in the hemolytic reaction. Science (1967) 0.98
Isoelectric focusing of human and guinea-pig C2: polymorphism of guinea-pig C2. Immunology (1970) 0.97
Detection of antigens of a new diethylnitrosamine-induced transplantable hepatoma by delayed hypersensitivity. J Natl Cancer Inst (1968) 0.97
Immune hemolysis and the functional properties of the second (C2) and fourth (C4) components of complement. II. Clustering of effective C42 complexes at individual hemolytic sites. J Immunol (1971) 0.97
Studies on the interaction between protein A and immunoglobulin G. II. Composition and activity of complexes formed between protein A and IgG. J Immunol (1978) 0.96
Correlation between the ability of tumor cells to resist humoral immune attack and their ability to synthesize lipid. J Immunol (1978) 0.96
Schistosoma mansoni: immunoblot analysis of adult worm proteins. Exp Parasitol (1985) 0.96
Studies on the terminal stages of immune hemolysis. V. Evidence that not all complement-produced transmembrane channels are equal. J Immunol (1979) 0.96
Cold-reacting antibodies: the enhancement of antibody fixation by the first component of complement (C'1a). J Immunol (1968) 0.96
Mouse complement: influence of sex hormones on its activity. Science (1966) 0.96
Immune hemolysis and the functional properties of the second (C2) and fourth (C4) components of complement. I. Functional differences among C4 sites on cell surfaces. J Immunol (1970) 0.95
Differences in cell-bound C8 sites on chicken erythrocytes measured by their reactivity with guinea pig and human C9. J Immunol (1980) 0.95
Lysis of tumor cells by antibody and complement. 1. Lack of correlation between antigen content and lytic susceptibility. J Natl Cancer Inst (1973) 0.94
Lysis of tumor cells by antibody and complement. VII. Complement-dependent 86Rb release--a nonlethal event? J Immunol (1976) 0.94
A new screening test for C3 nephritis factor based on a stable cell bound convertase on sheep erythrocytes. J Immunol Methods (1982) 0.94
Ultracentrifugation of the first component of complement: effects of ionic strength. J Immunol (1968) 0.94
Stimulation of the synthesis and release of lipids in tumor cells under attack by antibody and C. J Immunol (1978) 0.94
Cyclophosphamide pulse therapy in Wegener's granulomatosis. Nephrol Dial Transplant (1991) 0.93
Studies on the terminal stages of antibody-complement-mediated killing of a tumor cell. II. Inhibition of transformation of T to dead cells by 3'5' cAMP. J Immunol (1976) 0.92
Reversible loss of activity of the first component of complement (C'1) as a function of ionic strength. J Immunol (1968) 0.92
Complement research. Fundamental and applied. JAMA (1966) 0.91
Heat-labile, complement-like factor(s) of animal sera prevent(s) HIV-1 infectivity in vitro. J Acquir Immune Defic Syndr (1990) 0.91
Two-step mechanism of tumor graft rejection in syngeneic guinea pigs. II. Initiation of reaction by a cell fraction containing lymphocytes and neutrophils. J Natl Cancer Inst (1970) 0.91
Activation of the first component of complement evidence for an internal activation step. J Immunol (1972) 0.91
Interaction between components of the human classical complement pathway and immobilized Cibacron Blue F3GA. J Immunol Methods (1979) 0.90
Guinea pig leukemia L2C: characterization of chromosomes and attempts to demonstrate antigenicity. J Natl Cancer Inst (1970) 0.90
The terminal stages of immune hemolysis--a brief review. Mol Immunol (1980) 0.89
Complement activation and the prognostic value of C3a in patients at risk of adult respiratory distress syndrome. Clin Exp Immunol (1990) 0.89
The first component of complement in serum: evidence for a hitherto unrecognized factor in C1 necessary for internal activation. J Immunol (1973) 0.88
Structural characteristics of hemolytic antibodies as determined by the effects of ionizing radiation. J Immunol (1967) 0.88
Studies on the terminal stages of immune hemolysis. IV. Effect of metal salts. J Immunol (1979) 0.88
Allograft rejection in C'6 defective rabbits. J Exp Med (1967) 0.88
Generation of anaphylatoxin C3a in plasma and bronchoalveolar lavage fluid in trauma patients at risk for the adult respiratory distress syndrome. Crit Care Med (1992) 0.88
[3-dimensional imaging possibilities of thhe mid-face area using digital volume tomography based on a daver study of angle stable osteosynthesis]. Mund Kiefer Gesichtschir (2003) 0.87
Effect of aspirin on the complement system in vitro. Int Arch Allergy Appl Immunol (1980) 0.87
C5a-induced chemiluminescence of human granulocytes and its amplification by a serum factor. Immunobiology (1983) 0.87
Lysis of tumor cells by antibody and complement. VI. Enhanced killing of enzyme-pretreated tumor cells. J Immunol (1976) 0.87
Quantitative comparison of techniques used to measure complement-mediated cytotoxicity of nucleated cells. J Immunol (1975) 0.86
Systemic transfer of tumor immunity: delayed hypersensitivity and suppression of tumor growth. J Natl Cancer Inst (1970) 0.86
Tumor-specific antigens: detection by local transfer of delayed skin hypersensitivity. J Natl Cancer Inst (1969) 0.86
Resolution of the first component of guinea pig complement into three subunits, Clq, Clr and Cls, and their hybridization with human Cl subunits. Immunochemistry (1972) 0.85
Lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by acid-activated serum. Immunobiology (1983) 0.85
Studies on the terminal stages of antibody-complement-mediated killing of a tumor cell. I. Evidence for the existence of an intermediate, T. J Immunol (1976) 0.85
Studies on the interaction between protein A and immunoglobulin G. I. Effect of protein A on the functional activity of IgG. J Immunol (1978) 0.85
Deviated lysis: transfer of complement lytic activity to unsensitized cells. I. Generation of the transferable activity on the surface of complement resistant bacteria. Z Immunitatsforsch Exp Klin Immunol (1974) 0.85
Functional analysis and quantification of the complement C3 derived anaphylatoxin C3a with a monoclonal antibody. Clin Exp Immunol (1987) 0.84
Glycophorin A inhibits lysis by the complement attack phase. Immunobiology (1983) 0.84
Distinction between C8-mediated and C8/C9-mediated hemolysis on the basis of independent 86Rb and hemoglobin release. J Immunol (1980) 0.84
C4 does not bind to human and rabbit IgM during activation of the classical complement pathway on the red cell. J Immunol (1982) 0.84
Schistosoma mansoni: development of primary infections in mice genetically deficient or intact in the fifth component of complement. Parasitology (1982) 0.84
Lysis of tumor cells by antibody and complement. II. Lack of correlation between amount of C4 and C3 fixed and cell lysis. J Immunol (1975) 0.84
Analysis of the colloid osmotic step of complement-mediated immune hemolysis. J Immunol (1980) 0.83
Deviated lysis: Transfer of complement lytic activity to unsensitized cells II. Generation of the activity by inulin and by antigen antibody complexes. Z Immunitatsforsch Immunobiol (1976) 0.83
Antigenic specificity of hepatomas induced in strain-2 guinea pigs by diethylnitrosamine. J Natl Cancer Inst (1969) 0.83
Antigenic relationships between the first component (Cl) of human and guinea pig complement. J Immunol (1970) 0.82
Binding and activation of C4 and C3 on the red cell surface by non-complement enzymes. Mol Immunol (1988) 0.82
Inactivation of complement by L-asparaginase preparations not correlated with enzyme content. Nat New Biol (1972) 0.82
Presence of A-type and absence of C-type virus particles in a chemically induced guinea pig hepatoma. J Natl Cancer Inst (1974) 0.82
Abrogation of passively transferred tumor immunity in vivo by antigenically related tumor cells. J Natl Cancer Inst (1971) 0.82
Antibodies of patients infected with Schistosoma japonicum crossreact with diagnostic proteins of Schistosoma mansoni. J Tongji Med Univ (1986) 0.82